Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

Statement on 340B Drug Pricing Program Proposed Rule on Ceiling Price and Civil Monetary Penalties


Statement attributable to:
Bruce Siegel, MD, MPH
President and CEO
America’s Essential Hospitals

WASHINGTON—We are pleased that the Department of Health and Human Services (HHS) has responded to our lawsuit with other national organizations by proposing a Jan. 1, 2019, effective and compliance date for 340B Drug Pricing Program enforcement.

This change will put an end to the years-long delay of simple measures to hold drugmakers accountable in the 340B program. We encourage HHS to follow through with this proposal by promptly publishing a final rule in time to meet the new deadline.

The newly proposed regulation also calls on HHS to provide pricing information to 340B participating hospitals and other providers through a closed website. This website is essential to enforcement of the 340B program. We strongly encourage HHS to launch the website as soon as possible after Jan. 1, 2019.

# # #

About America’s Essential Hospitals
America’s Essential Hospitals is the leading champion for hospitals and health systems dedicated to high-quality care for all, including the most vulnerable. We support our more than 325 members with advocacy, policy development, research, and education. Communities depend on essential hospitals to provide specialized, lifesaving services; train the health care workforce; advance public health and health equity; and coordinate care. Essential hospitals innovate and adapt to lead the way to more effective and efficient care. Learn more at

Carl Graziano


About the Author

Dedicated staff at America's Essential Hospitals work together to produce high-quality, reliable content. Please view the about section for more details about staff.

Previous Next
Test Caption
Test Description goes like this